This Market Cannot be Killed... Jimmy Mengel Photo By

New Post Public Reply Private Reply Replies (0) Message Board
BionicBen
4,863
This Market Cannot be Killed...
Jimmy Mengel Photo By Jimmy Mengel
Written Tuesday, February 28, 2017
The genie is out of the bottle…

Legal marijuana is here to stay, and marijuana investing will continue be the greatest moneymaking opportunity of our lives.

Do not fear the latest fearmongering coming from the Feds.

If you haven’t heard yet, legal marijuana came up during a White House press briefing. When asked if the Trump administration would crack down on states that allow legal recreational marijuana, Sean Spicer said:

"I do believe you will see greater enforcement of it.”

For those who aren’t aware, while states have been free to pass legalized marijuana laws, the federal laws still recognize marijuana as a schedule I controlled substance — which is still technically illegal. The Feds can go after legal cannabis companies: raiding shops, destroying farms, and busting up medical marijuana operations.

Now, as a marijuana investor who runs a marijuana investing newsletter, that statement is obviously not music to my ears.

In fact, after Spicer made the remarks, many of my stocks dropped 5 to 10%.

But instead of panicking, I simply doubled down on the industry that some say will “create more millionaires than Microsoft."

There are simply too many political and social reasons that cracking down on it from the federal level doesn't make sense. It would destroy thousands of well-paying U.S. jobs, steal away a huge amount of state tax dollars, and anger a population that has clearly embraced legalized marijuana with its votes.

That’s why I’d say you should start investing in marijuana right now...

Advertisement
101 Companies Offer a Secret $50 Retirement Plan
That Pays Up to $1.1 Million in Benefits

According to law, Microsoft, Cisco, Amgen, and other popular companies are NOT part of this retirement plan.

It’s a small pool of companies that offer you a chance to put up $50 (sometimes more) and watch it grow into hundreds of thousands of dollars, sometimes as much as $1.1 million in benefits, as some folks have made.

This plan is not advertised, and it's kept a secret by Congress. But anyone can legally take advantage of this unorthodox retirement plan.

You can get the full details here.

First off — Trump himself campaigned on the fact that states should be able to make the laws they see fit for their citizens.

"In terms of marijuana and legalization, I think that should be a state issue, state-by-state," he said in October.

He also mentioned that he was “in favor of medical marijuana 100%.”

I seriously doubt Trump is going to spend one iota of his dwindling political capital on cracking down on states' rights that he clearly supported during his campaign. Recent surveys show that over 60% of the country is in favor of legalization — the highest ever recorded.

"Picking a fight with the growing number of states that are enacting popularly supported marijuana laws would be a huge distraction that the White House just does not need right now. We're way more popular than they are," according to Paul Armentano, deputy director of the advocacy group NORML.

Secondly, his attorney general, Jeff Sessions — who is notoriously anti-legalization — hasn’t given any good reasons for a federal crackdown. He did mention that he has been informed that violence has increased in areas with marijuana legalization.

“We’re seeing real violence around that. Experts are telling me there’s more violence around marijuana than one would think and there’s big money involved.”

He’s right about one thing — there is big money involved, which is why I’m so bullish on it. But he is completely wrong about violent crime. Violent crime has actually decreased in states that have legalized cannabis. Not only has legalizing a product that used to be sold by criminal gangs and foreign cartels cut down on crime and violence, it has actually lowered youth access to marijuana and resulted in far fewer arrests.

A new study also suggests that states with medical marijuana laws on the books have fewer traffic fatalities, particularly among young drivers.

So if Sessions even thinks about sending his goons to close up legally operating shops and facilities, he’ll be met with a slew of facts that prove otherwise.

Sessions also admitted that "States can pass the laws they choose.”

Thirdly, even members of his own party are speaking out against the idea of a federal crackdown…

Advertisement
A groundbreaking technology poised to disrupt the entire solar industry...

A material that more than doubles the efficiency limit of silicon...

The patents behind it all...

And the tiny, $0.15 stock with exclusive rights to its production.

tce-tiny-dots-video-preview

Point blank: this is NOT an opportunity you want to miss.

Colorado Governor John Hickenlooper — who was against legalization in his state — has recognized the value and urged the government to let the states do what is best for them.

"I opposed the legalization of recreational marijuana in Colorado. I spoke openly against it, but it passed in Colorado by 55 to 45%. It is now part of our constitution," Hickenlooper said last week.

"I think it's the wrong time to pull back from this experiment, and if the federal government's going to come and begin closing in and arresting people that are doing what's legal in different states, my God, it creates a level of conflict that's going to be very difficult."

Democrats tend to agree even more...

Senator Ron Wyden, a Democrat from Oregon, urged the federal government to "respect the decisions of Oregon voters."

"The Trump administration is threatening states' rights, including the rights of one in five Americans who live in a state where marijuana is legal," he said. "I will fight hard against ridiculous federal government intrusions into our state."

He won’t be the only one, I assure you...

The point is, political figures who represent the states that have seen so much prosperity from the new industry are lining up to fight against any federal intervention in their business.

It’s mostly because the industry is not only extremely popular with their constituencies, it has also brought tons of new jobs and tax revenue to their states…

Trump ran on bringing good jobs back to American workers. No other new industry has done as great a job at fulfilling that promise than the legal cannabis industry.

In fact — according to the Department of Labor and Statistics themselves — legal cannabis will account for more new jobs than the government, manufacturing, or utilities.

“These numbers confirm that cannabis is a major economic driver and job creation engine for the U.S. economy. While we see a potential drop in total number of U.S. jobs created in 2017, as reported by Kiplinger, as well as an overall expected drop in GDP growth, the cannabis industry continues to be a positive contributing factor to growth at a time of potential decline,” according to Giadha Aguirre De Carcer, founder and CEO of New Frontier Data.

She went on to say that even if there were a chilling of the industry over the next couple of years, projected total market sales are “expected to exceed $24 billion by 2025, with the possibility of almost 300,000 jobs by 2020.”

And with big business comes big taxes, and the legal marijuana industry is raking them in…

In Colorado alone, legal marijuana sales reached $996 million last year, bringing in $163 million in tax dollars. That makes it the second largest revenue source — three times larger than alcohol, and 14% larger than casinos. According to the Marijuana Policy Group, marijuana tax revenues will overtake cigarettes by 2020.

Washington State brought in $77 million its first year — which is impressive — but that figure is projected to jump to around $270 million this year.

But California will hit the jackpot: some state analysts estimate local governments could see $1 billion in revenue from the production and legal sale of marijuana.

Once the Pandora’s Box of billions in tax revenue is opened, I don’t think even the “reefer madness” of someone like Jeff Sessions can close it.

Advertisement
The Culmination of a Lifetime of Study on Gold

Precious metals expert Mr. James Dines believes we’re on the verge of an historic rally in gold prices...

He’s also the author of the bestselling book Goldbug!, which is widely considered to be the “bible” of gold and silver investing.

In it, you’ll see why Mr. Dines thinks:

Gold is going to $5,000 an ounce

Silver is going to $300 an ounce

The shocking reason silver’s price could exceed the price of gold, which will happen near their final peaks

We’re giving the book away for free.

Click here to get your copy.

But to tell you the truth, as an investor, I’m not really concerned if the Feds close up shop on every marijuana facility in this country.

That’s because the real money to be made right now is up north… in Canada.

On April 20th, leading Canadian officials are set to make an explosive announcement. A legal move that will singlehandedly unleash a $150 BILLION untapped market...

I’ve recently banked gains of 830%, 320%, and 120% on Canadian marijuana companies, and I’m only just getting started. This new announcement will blow the roof off of the entire industry — giving you the chance to bank a once-in-a-lifetime windfall.

I have put together a presentation about exactly how to play this historic investment opportunity without any fear of what’s happening in the U.S of A.

Simply accept my invitation here, and we’ll send you the free presentation on March 14th.

I hope you join me for what will be the single greatest wealth opportunity of your lifetime.

Make sure you’re on the list...

Godspeed,
Jimmy Mengel

Jimmy Mengel

follow basic @mengeled on Twitter

Jimmy is a managing editor for Outsider Club and the Investment Director of the personal finance advisory The Crow's Nest. You may also know him as the architect behind the wildly popular finance and investing website Wealth Wire, where he's brought readers the stories behind the mainstream financial news each and every day. For more on Jimmy, check out his editor's page.

*Follow Outsider Club on Facebook and Twitter.

Advertisement
How rich will you be when gold hits $8,000?

Use our brand new “Gold Gain Multiplier” to find out.

EVERY time gold prices go up, it multiplies those increases by crazy amounts.

In other words, for every $1 gold goes up, you stand to make $44.

See why our brand-new gold analyst uses this tool to advise his high-net-worth clients... and how you can put it to use for yourself today as we enter a new gold bull market.

Enjoy reading this article? Click here to like it and receive similar articles to read!
Browse Our Archives
Are We On The Verge of Another Rare Earth Crisis?
Buffett: Do What I Say, Not What I Do
How To Buy 'Discount' Tesla Shares
Fear the Greed: Traders Ignore Volatility Risk
Mr. James Dines: This Is the Most Undervalued Metal on the Planet
Having trouble viewing this issue? View Web Version

This email was sent to archer413@gmail.com. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, get more info here, including our privacy policy and information on how to manage your subscription.

To ensure that you receive future issues of Outsider Club, please add newsletter@outsiderclub.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance.

Outsider Club, Copyright © 2017, Angel Publishing LLC & Outsider Club LLC, 111 Market Place #720, Baltimore, MD 21202. For Customer Service, please call (877) 303-4529. All rights reserved. No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. Angel Publishing and Outsider Club does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question. This letter is not intended to meet your specific individual investment needs and it is not tailored to your personal financial situation. Nothing contained herein constitutes, is intended, or deemed to be – either implied or otherwise – investment advice. Neither the publisher nor the editors are registered investment advisors. This letter reflects the personal views and opinions of Nick Hodge and that is all it purports to be. While the information herein is believed to be accurate and reliable it is not guaranteed or implied to be so. Neither Nick Hodge, nor anyone else, accepts any responsibility, or assumes any liability, whatsoever, for any direct, indirect or consequential loss arising from the use of the information in this letter. The information contained herein is subject to change without notice, may become outdated and may not be updated. Nick Hodge, entities that he controls, family, friends, employees, associates, and others may have positions in securities mentioned, or discussed, in this letter. No part of this letter/article may be reproduced, copied, emailed, faxed, or distributed (in any form) without the express written permission of Nick Hodge or the Outsider Club. Unauthorized reproduction of this newsletter or its contents by Xerography, facsimile, or any other means is illegal and punishable by law.

North American Cannabis Holdings, Inc. (USMJ) Stock Research Links

USMJ Board Company Profile Buy Rating Time & Sales News Filings Financials
Disclaimer:
There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator.
Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.
There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in all and any posts.
My posts are NOT investment advice. I am not paid to post.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading

Top 5 Most Recently Viewed Articles

Vaccinex Unveils Efficacy Insights for Pepinemab in Alzheimer’s Study

Updated Category News Views 71

Vaccinex Provides Update on Pepinemab Study for Alzheimer’s Disease ROCHESTER, N.Y. — Vaccinex, Inc. (NASDAQ: VCNX), a forward-thinking biotechnology firm, is making significant strides in the treatment of Alzheimer's disease (AD) and cancer. The company is focused on a unique approach through the inhibition of Semaphorin 4D (SEMA4D). Recently, it was announced that...

Continue Reading
Legal Inquiry into Netflix, Inc. (NFLX) Attracts Investor Attention

Updated Category News Views 287

Understanding the Investigation into Netflix, Inc. Recently, the law firm Robbins Geller Rudman & Dowd LLP has initiated a formal investigation into Netflix, Inc. (NASDAQ: NFLX). This inquiry primarily focuses on potential violations of U.S. federal securities laws that may have occurred within the company. The Implications for Investors This investigation comes at a...

Continue Reading
Norway's Wealth Fund Expands Portfolio with London Investment

Updated Category News Views 221

Norway's Sovereign Wealth Fund Takes Bold Step in London Norway's sovereign wealth fund, expertly managed by Norges Bank Investment Management, has recently made headlines with its strategic acquisition of a 25% stake in a notable portfolio of office and retail properties located in London's prestigious Mayfair district. Significant Investment in a Prime Location This...

Continue Reading
Exagen Inc. Announces New Biomarkers and Financial Success

Updated Category News Views 291

Exagen Inc. Introduces Groundbreaking Biomarkers for Autoimmune Diseases Innovative testing aims to enhance patient diagnosis and care Exagen Inc. (Nasdaq: XGN), a pioneering company in autoimmune testing, has achieved a significant milestone by receiving conditional approval from the New York State Department of Health for its advanced assays to diagnose systemic lupus...

Continue Reading
Pacaso's Financial Growth in 2025: A Closer Look At Results

Updated Category News Views 1306

Pacaso Shows Promising First Half Financial Performance Pacaso, the innovative platform for co-owned luxury vacation homes, has recently shared its financial results for the first half of 2025, demonstrating strong stability and improved efficiency despite a challenging broader housing market. The company reported an impressive adjusted gross profit while managing to...

Continue Reading